Global Tissue Banking Market 2022-2028

Description

List of Tables

Global Tissue Banking Market Size, Share & Trends Analysis Report, By Products (Equipment and Consumables & Media,) By Applications (Medical Research, Therapeutics, and Others), and Forecast 2022-2028.

The global Tissue bankingmarket is anticipated to grow at a substantial CAGR of 9.3% during the forecast period. Increasing demand for bio banks with growing investment for drug development for various diseases is increasing the global tissue bank market.A biobank is a practice of creating wide-range repositories for the collection, storage, and distribution of human samples such as blood, plasma, serum, urine, tissues, cells, and others.Globally, there are several types of biobanks, such as diseases-oriented biobanks, population-based biobanks, tissue banks, and blood banks which are contributing to the market growth. According to American red cross around 29,000 units of red blood cells are needed every day in the U. S., Nearly 5,000 units of platelets and 6.500 units of plasma are needed daily, Nearly 16 million blood components are transfused each year in the U.S.

The global tissue banking market is segmented based on products, and application. Based on products the market is sub-divided into equipment and consumables & media. The equipment used for tissue banking includes thawing equipment, quality control equipment, cryopreservation equipment, and others. Tissue banking equipment is expected to hold a significant share in the global market. Increasing product development is one of the major factors contributing to the growth of the market. Further, on the basis of application, the market is segmented into medical research and therapeutics will experience the major growth in the tissue banking market industry. Government and private funding for the research is also fuelling the growth for then tissue bank market.

Geographically market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World.North America dominates the market and is expected to continue its presence over the forecast period. The growth can be attributed to the increasing R&D activities and increasing adoption of tissue banking solutions and increasing tissue donorsforvarious transplantation. As according to american association of tissue banks (AATB), around 58,000 peoples donates tissues in US annually.The main role of tissue banking is to ,provide tissues for different treatementsas a result, the demand for Tissue bankingis set to increase over the coming years, which has contributed to the growth of the market in the North America region.

The major companies serving the global tissue bankingmarket includes Custom Biogenic Systems, Inc., Eppendrof AG, Genzyme Corp. (A Sanofi Company), GlaxoSmithKline PLC, Merck KGaA and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in 2022 Sanofi and IGM Biosciences announce collaboration agreement for oncology, immunology and inflammation targets. This collaboration is done to create, develop, manufacture and commercialize new class of potential therapeutics combining the superior features of multi-valent IgM antibodies over conventional IgG antibodies for stimulating cell surface receptors

Research Methodology

The market study of the global tissue bankingmarket is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

Financial reports of companies involved in the market.
Whitepapers, researchpapers, and news blogs.
Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. Global Tissue bankingMarket Research and Analysis by Products

2. Global Tissue bankingMarket Research and Analysis by Application

The Report Covers

Comprehensive research methodology of the global tissue banking market.
This report also includes a detailed and extensive market overview with key analyst insights.
An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
Analysis of regional regulations and other government policies impacting the global Tissue bankingmarket.
Insights about market determinants that are stimulating the global Tissue bankingmarket.
Detailed and extensive market segments with the regional distribution of forecasted revenues.
Extensive profiles and recent developments of market players.

Product Code: OMR2017114

Category-Biotechnology

1. Report Summary

Current Industry Analysis and Growth Potential Outlook
Impact of COVID-19 on the GlobalTissue banking Market
Recovery Scenario of GlobalTissue banking Market
1.1. Research Methods and Tools
1.2. Market Breakdown
- 1.2.1. By Segments
- 1.2.2. BY Region

2. Market Overview and Insights

2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
- 2.2.1. Key Findings
- 2.2.2. Recommendations
- 2.2.3. Conclusion

3. Competitive Landscape

3.1. Key CompanyAnalysis
- 3.1.1. Thermo Fisher Scientific Inc.
  - 3.1.1.1. Overview
  - 3.1.1.2. Financial Analysis
  - 3.1.1.3. SWOT Analysis
  - 3.1.1.4. Recent Developments
- 3.1.2. Merck KGaA
  - 3.1.2.1. Overview
  - 3.1.2.2. Financial Analysis
  - 3.1.2.3. SWOT Analysis
  - 3.1.2.4. Recent Developments
- 3.1.3. Beckman Coulter, Inc.
  - 3.1.3.1. Overview
  - 3.1.3.2. Financial Analysis
  - 3.1.3.3. SWOT Analysis
  - 3.1.3.4. Recent Developments
- 3.1.4. Stryker Corp.
  - 3.1.4.1. Overview
  - 3.1.4.2. Financial Analysis
  - 3.1.4.3. SWOT Analysis
  - 3.1.4.4. Recent Developments
- 3.1.5. Zimmer Biomet Holdings, Inc.
  - 3.1.5.1. Overview
  - 3.1.5.2. Financial Analysis
  - 3.1.5.3. SWOT Analysis
  - 3.1.5.4. Recent Developments
3.2. Key Strategy Analysis
3.3. Impact of Covid-19 on Key Players

4. Market Determinants

4.1. Motivators
4.2. Restraints
4.3. Opportunities

5. Market Segmentation

5.1. GlobalTissue banking Market, by Products
- 5.1.1. Equipment
- 5.1.2. Media & Consumables
5.2. Global Tissue banking Market, by Applications
- 5.2.1. Medical Research & Drug Development
- 5.2.2. Therapeutics
- 5.2.3. Others

6. Regional Analysis

6.1. North America
- 6.1.1. United States
- 6.1.2. Canada
6.2. Europe
- 6.2.1. UK
- 6.2.2. Germany
- 6.2.3. Italy
- 6.2.4. Spain
- 6.2.5. France
- 6.2.6. Rest of Europe
6.3. Asia-Pacific
- 6.3.1. China
- 6.3.2. India
- 6.3.3. Japan
- 6.3.4. South Korea
- 6.3.5. Rest of Asia-Pacific
6.4. Rest of the World

7. Company Profiles

7.1. AMS Biotechnology Ltd.
7.2. AstaZeneca PLC
7.3. Beckman Coulter Inc.
7.4. BioCision LLC.
7.5. BioStorage Technologies, Inc.
7.6. Custom Biogenic Systems, Inc.
7.7. Eppendrof AG
7.8. Genzyme Corp. (A Sanofi Company)
7.9. GlaxoSmithKline PLC
7.10. Merck KGaA
7.11. Organ Recovery Systems, Inc.
7.12. Pfizer Inc.
7.13. Regeneron Pharmaceuticals, Inc.
7.14. Stryker Corp.
7.15. Taylor Wharton
7.16. Tecan Group
7.17. Teva Pharmaceuticals Industries Ltd.
7.18. Thermo Fisher Scientific Inc.
7.19. Zimmer Biomet Holdings, Inc.